Spero Therapeutics, Inc. (SPRO)
1.22
+0.10
(+8.93%)
USD |
NASDAQ |
Oct 20, 16:00
1.23
+0.01
(+0.82%)
Pre-Market: 20:00
Spero Therapeutics Gross Profit (TTM) : 0.00 for June 30, 2026
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 6.015M |
| December 31, 2024 | 6.015M |
| September 30, 2024 | 77.80M |
| June 30, 2024 | 101.08M |
| March 31, 2024 | 95.50M |
| December 31, 2023 | 95.89M |
| September 30, 2023 | 70.10M |
| June 30, 2023 | 47.42M |
| March 31, 2023 | 47.59M |
| December 31, 2022 | 47.03M |
| September 30, 2022 | 1.244M |
| June 30, 2022 | 0.647M |
| March 31, 2022 | 0.042M |
| Date | Value |
|---|---|
| December 31, 2021 | -0.153M |
| September 30, 2021 | -0.748M |
| June 30, 2021 | -0.748M |
| March 31, 2021 | -0.748M |
| December 31, 2020 | -0.39M |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Inovio Pharmaceuticals, Inc. | -3.015M |
| Fortress Biotech, Inc. | 40.31M |
| Kura Oncology, Inc. | 75.37M |
| ACADIA Pharmaceuticals, Inc. | 1.038B |
| Alnylam Pharmaceuticals, Inc. | 3.827B |